What to Expect
Gold Sponsor Servier is pleased to host their 2024 Early Innovation Award at LabCentral! This Golden Ticket will go to a startup who is driving scientific innovation in areas of high unmet need, including hard-to-treat diseases in oncology, neuroscience, and immuno-inflammation, as well as those pursuing research in translational medicine, drug development technologies, and drug delivery platforms. Come and network while supporting the competing companies!
Gold Sponsor Servier is pleased to host their 2024 Early Innovation Award at LabCentral! This Golden Ticket will go to a startup who is driving scientific innovation in areas of high unmet need, including hard-to-treat diseases in oncology, neuroscience, and immuno-inflammation, as well as those pursuing research in translational medicine, drug development technologies, and drug delivery platforms. Come and network while supporting the competing companies!
Agenda
4 PM: Registration and networking
4:30 PM: Opening remarks
4:50 PM: Pitches begin
5:25 PM: Judges Deliberation
5:30 PM: Winner Announcment
5:35 PM: Networking
7PM: Event close
4 PM: Registration and networking
4:30 PM: Opening remarks
4:50 PM: Pitches begin
5:25 PM: Judges Deliberation
5:30 PM: Winner Announcment
5:35 PM: Networking
7PM: Event close
Finalists
Speakers
Irene Blat, PHD
Senior Director, Search & Evaluation Oncology
External Innovation
Ross Jeggo, PHD
Global Head of Neuroscience & Immuno-Inflamation Therapeutic Area
Judges
Olga Kolman, MD
Pipeline Strategy Leader
Oncology & Rare Disease
Pat Fetaya
Head of U.S. Business Development
Dale Porter
Head of U.S. Oncology & Immuno-Oncology Research